SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : CYTC - How High Can It Go!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Chuck. Edwards who wrote (46)9/30/1997 10:12:00 AM
From: wolfdog2   of 185
 
I just took a small position in CYTC this morning. Because of the additional expense in using ThinPrep over a traditional pap smear, there may be some reluctance on the part of insurers initially to reimburse of ThinPrep. In the long run it maybe cheaper to use it, however. Why? Well there is the malpractice issue that Chuck alluded to. Also, from a financial stand point if you can catch a malignancy early on there may be a net savings to the insurer. Most certainly there's a benefit to the patient. It will be interesting to see if some of the women's groups pick up the issue in the event that some insurers won't fully reimburse for ThinPrep.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News